HelenAnnMintz-HittnerMD

PubMed

• 2 citations
  Neurodevelopmental outcome of preterm infants enrolled in myo-inositol randomized controlled trial
  Ira Adams-Chapman, Kristi L. Watterberg, Tracy L. Nolen, Shawn Hirsch, Carol A. Cole, C. Michael Cotten, William Oh, Brenda B. Poindexter, Kristin M. Zaterka-Baxter, A...> ;Journal of Perinatology. 2021 Mar 23
• 20 citations
  Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial.
  Dale L. Phelps, Kristi L. Watterberg, Tracy L. Nolen, Carol A. Cole, C. Michael Cotten, William Oh, Brenda B. Poindexter, Kristin M. Zaterka-Baxter, Abhik Das, Conra B...> ;JAMA. 2018 Oct 23
• 68 citations
  Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity
  Kathleen A. Kennedy, Helen A. Mintz-Hittner> ;Journal of AAPOS. 2018 Feb 1
• 7 citations
  Retinopathy of Prematurity: Intravitreal injections of bevacizumab: timing, technique, and outcomes
  Helen A. Mintz-Hittner> ;Journal of AAPOS. 2016 Dec 1
• 22 citations
  Review of effects of anti-VEGF treatment on refractive error
  Helen A. Mintz-Hittner, Megan M. Geloneck> ;Eye and Brain. 2016 Jun 15
• 108 citations
  Clinical Management of Recurrent Retinopathy of Prematurity after Intravitreal Bevacizumab Monotherapy
  Helen A. Mintz-Hittner, Megan M. Geloneck, Alice Z. Chuang> ;Ophthalmology. 2016 Sep 1
• 218 citations
  Refractive Outcomes Following Bevacizumab Monotherapy Compared With Conventional Laser Treatment: A Randomized Clinical Trial
  Megan M. Geloneck, Alice Z. Chuang, W. Lloyd Clark, Michael G. Hunt, Alan A. Norman, Eric A. Packwood, Khaled A. Tawansy, Helen A. Mintz-Hittner> ;JAMA Ophthalmology. 2014 Nov 1
• 37 citations
  Treatment of retinopathy of prematurity with vascular endothelial growth factor inhibitors.
  Helen A. Mintz-Hittner> ;Early Human Development. 2012 Dec 1
• 18 citations
  Intravitreal pegaptanib as adjunctive treatment for stage 3+ ROP shown to be effective in a prospective, randomized, controlled multicenter clinical trial.
  Helen A. Mintz-Hittner> ;European Journal of Ophthalmology. 2012 May 6
• 59 citations
  Recessive mutations in TSPAN12 cause retinal dysplasia and severe familial exudative vitreoretinopathy (FEVR).
  James A. Poulter, Alice E. Davidson, Manir Ali, David F. Gilmour, David A. Parry, Helen A. Mintz-Hittner, Ian M. Carr, H.M. Bottomley, Vernon Long, Louise Downey, Pana...> ;Investigative Ophthalmology &amp; Visual Science. 2012 May 14
• 883 citations
  Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
  Helen A. Mintz-Hittner, Kathleen A. Kennedy, Alice Z. Chuang> ;The New England Journal of Medicine. 2011 Feb 17
• 27 citations
  Avastin as monotherapy for retinopathy of prematurity.
  Helen A. Mintz-Hittner> ;Journal of AAPOS. 2010 Feb 1
• 129 citations
  The Use of Anti-VEGF Intravitreal Injections for Vision Threatening Stage 3 Retinopathy of Prematurity: Risk-Benefit Ratio
  Helen A. Mintz-Hittner> ;Retina. 2009 Apr 1
• 39 citations
  Antivascular endothelial growth factor for retinopathy of prematurity.
  Helen A. Mintz-Hittner, Leah M Best> ;Current Opinion in Pediatrics. 2009 Apr 1
• Correspondence.
  Mintz-Hittner, H.A.> ;Retina. 2009-03-02
• 67 citations
  Intravitreous Bevacizumab as Anti–Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity: A Morphologic Study
  Lingkun Kong, Helen A. Mintz-Hittner, Rebecca L. Penland, Francis L. Kretzer, Patricia Chévez-Barrios> ;Archives of Ophthalmology. 2008 Aug 11
• 17 citations
  X-linked exudative vitreoretinopathy caused by an arginine to leucine substitution (R121L) in the Norrie disease protein
  Kimberly Johnson, Helen A. Mintz-Hittner, Yvette P. Conley, Robert E. Ferrell> ;Clinical Genetics. 2008 Jun 28
• 11 citations
  Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.
  Helen A Mintz-Hittner, Ronald R Kuffel Jr> ;Retina. 2008 Jun 1
• 61 citations
  Partial triplication and deletion of 13q: study of a family presenting with bilateral retinoblastomas.
  Vincent M. Riccardi, Helen M. Hittner, U Francke, S Pippin, G P Holmquist, F L Kretzer, Robert E. Ferrell> ;Clinical Genetics. 2008 Apr 23
• 24 citations
  Further evidence of genetic heterogeneity in familial exudative vitreoretinopathy; exclusion of EVR1, EVR3, and EVR4 in a large autosomal dominant pedigree
  Carmel Toomes, L M Downey, H.M. Bottomley, Helen A. Mintz-Hittner, Chris F. Inglehearn> ;The British Journal of Ophthalmology. 2005 Feb 1
• 32 citations
  Laser in situ keratomileusis for treated anisometropic amblyopia in awake, autofixating pediatric and adolescent patients
  Christopher B. Phillips, Thomas C. Prager, Glynett McClellan, Helen A. Mintz-Hittner> ;Journal of Cataract and Refractive Surgery. 2004 Dec 1
• 24 citations
  Laser in situ keratomileusis for high hyperopia in awake, autofixating pediatric and adolescent patients with fully or partially accommodative esotropia.
  Christopher B. Phillips, Thomas C. Prager, Glynett McClellan, Helen A. Mintz-Hittner> ;Journal of Cataract and Refractive Surgery. 2004 Oct 1
• 38 citations
  VSX1 (RINX) mutation with craniofacial anomalies, empty sella, corneal endothelial changes, and abnormal retinal and auditory bipolar cells.
  Helen A. Mintz-Hittner, Elena V. Semina, Laura J. Frishman, Thomas C. Prager, Jeffrey C. Murray> ;Ophthalmology. 2004 Apr 1
• 1 citations
  Traumatic optic nerve injury occurring after forceps delivery of a term newborn
  Sherif K Khalil, Richard G. Urso, Helen A. Mintz-Hittner> ;Journal of AAPOS. 2003 Apr 1
• 1 citations
  Microcornea and subluxated lenses due to a splicing error in the fibrillin-1 gene in a patient with Marfan syndrome
  Mark C. Vital, Helen A. Mintz-Hittner, Dianna M. Milewicz> ;Archives of Ophthalmology. 2003 Apr 1
• Join now to see all